Is Utah making progress in the fight against opioid-related deaths?
Recent CDC data reported that between October 2023 and September 2024, the United States saw its lowest death rate in a 12-month timeframe since 2020. During that period, there were 87,000 deaths compared to 114,000 the year before.
'It is unprecedented to see predicted overdose deaths drop by more than 27,000 over a single year,' said Allison Arwady, Director of CDC's National Center for Injury Prevention and Control, per the report. 'That's more than 70 lives saved every day,' and is happening because 'we are more rapidly identifying emerging drug threats and supporting public health prevention and response activities in communities across America.'
Utah continues to face a significant drug trafficking threat, as demand indicates the state is a destination for illegal sales. Victims of drug-related deaths in Utah more frequently succumbed to synthetic opioids like fentanyl or methamphetamine mixed with other substances, and less to prescribed medication, which was historically more common, according to the Utah Office of the Medical Examiner.
Fentanyl is approximately 100 times more potent than morphine, while carfentanil — an opioid used to tranquilize elephants — is 10,000 times more potent. A fatal dose of fentanyl may be as little as 2 milligrams. Similarly, just 0.02 milligrams of carfentanil can end a life. Both are being trafficked for use in the state of Utah.
'The sharp increase in the number of fentanyl-involved deaths outpaces reductions in deaths from prescription opioids,' Dr. Deirdre Amaro, Utah's chief medical examiner said. 'We will likely see an increase in the drug overdose death rate if this trend continues.'
The U.S. saw a slight drop in opioid-related deaths since its yearly peak ending mid-July 2023 at 85,387 deaths, Addiction-Rep shared with the Deseret News via email, highlighting detailed statistics from their national report on America's opioid crisis.
By June 2024, national opioid-related deaths decreased by 16% to 71,484 deaths the following year.
The following opioid statistics regarding the U.S. were also shared:
From June 2023 to June 2024, synthetic opioids like fentanyl remained the most common drug involved in opioid deaths in the state but decreased by 20% year-over-year.
Deaths caused by heroin have seen a 'drastic' decrease, showing a fallen rate in the last five years from 14,743 in 2019 to 3,242 in 2024 — a nearly 80% decline.
Men are the most common victims of drug-related deaths on a state and national level. But, fatality rates have decreased in both men and women by 19% year-over-year.
For Utah specifically, from June 2022 to June 2023, the state experienced 492 opioid-related deaths. By June 2024, the rate increased to 503, 'still, when looking at Utah's rate of deaths per 100k people, the state experienced a modest year-over-year decline of 0.2% (due to the Utah population increasing).'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CNET
25 minutes ago
- CNET
The 13 Foods That Could Save Your Kidneys and Your Wallet
Your kidneys work quietly in the background every day, doing far more than most people realize. They filter waste from your blood, keep fluid levels balanced, help regulate hormones and play a role in everything from managing blood pressure to supporting healthy energy levels. Despite being so important, kidney health often does not get the attention it deserves. According to the CDC, more than 1 in 7 adults in the US are living with chronic kidney disease, and many are unaware they have it. That is why daily care and early prevention matter so much. Looking after your kidneys now can help them keep doing their job for years to come, and a few small, consistent habits can make a big difference. Don't miss any of CNET's unbiased tech content and lab-based reviews. Add us as a preferred Google source on Chrome. Fortunately, you don't need to make dramatic lifestyle changes to support kidney health. Incorporating a handful of nutrient-rich superfoods into your regular meals can make a significant difference. These foods help reduce inflammation, support healthy blood flow, and ease the load on your kidneys so they can keep doing their job. If you're looking to give your kidneys the boost they need, these 13 simple additions to your diet are a great way to start. Your diet and gut health also play a major role in your wellness, especially when it comes to keeping your kidneys healthy. There are 13 superfoods you should keep in mind when considering natural ways to give your kidney health a boost. Read more: 6 Important Blood Tests You May Need for Your Overall Health 13 superfoods for kidney health 1. Cabbage This nutrient-dense vegetable is low in both potassium and sodium while packing in fiber, vitamins C and K and more. Plus, cabbage is versatile. You can use it in salads and slaws, but you can also use it as a wrap for tacos, sandwiches and more. 2. Fatty fish Fish delivers protein, and when you choose a fatty fish like tuna, salmon or trout, you're also getting omega-3 fatty acids. Omega-3 fats may help reduce fat levels (triglycerides) in the blood and may also lower blood pressure, according to the National Kidney Foundation. If you have CKD, you may need to keep an eye on the phosphorus and potassium levels of the fish you choose. The National Kidney Foundation has a chart you can use to determine levels in specific types of fish. Although, it's best to consult with your doctor. Jacobs3. Bell peppers Like cabbage, bell peppers pack in lots of good nutrients with low levels of potassium. With them, you get vitamins B6, B9, C and K, plus fiber. They deliver antioxidants too. You can slice them and eat them with dips or roast them and add them to dinner. 4. Cranberries Cranberries help to prevent urinary tract infections. These usually stay in your bladder, they can travel up to your kidney, making kidney problems worse. Fortunately, regularly consuming cranberries can help you avoid this unwelcome situation. Plus, cranberries have antioxidants that can help fight inflammation, and they can boost your heart and digestive health. It turns out, these tart berries aren't just for the Thanksgiving table. 5. Blueberries We've talked about some of the best foods for kidneys, but you can take it a step further. The question is: What foods help repair kidneys? Blueberries deliver. With high levels of antioxidants and loads of vitamin C and fiber, blueberries are all-around healthy. They can also help to reduce inflammation and support bone health, reversing some of the issues that can come with CKD. 6. Dark, leafy greens There are plenty of reasons to turn to dark, leafy greens like spinach or kale. They deliver so many nutrients that they can help you get key vitamins and minerals, plus immunity-boosting benefits. Be advised that greens can come with a decent amount of potassium. If you have CKD, talk to your doctor before adding more of these to your diet. 7. Olive oil Rich in antioxidants and healthy fatty acids, olive oil can boost your overall wellness. A study from Harvard University found that olive oil may lower cholesterol levels and the risk of cardiovascular disease, dementia and some types of cancer. Beyond all this, it can help you add flavor to dishes without turning to salt or butter. To get more antioxidants, choose unrefined or cold-pressed olive oil that's virgin or extra virgin. 8. Garlic Another antioxidant-rich, inflammation-fighting food, garlic also contains a specific compound called allicin. For people with CKD, allicin — an active compound found in garlic — worked just as effectively to help protect kidney health as a prescription drug. If you're looking for the best foods for your kidneys, garlic has to make the list. Plus, it's an excellent way to add flavor when you're skimping on salt. 9. Onions From the same family as garlic, onions give you another excellent and salt-free way to add flavor (bonus points if you saute them in olive oil). Onions also deliver important nutrients like vitamins B6 and C, manganese and copper. They also contain quercetin, a chemical that can help your body fight cancer, and organic sulfur compounds that can reduce your risk of high blood pressure, stroke and heart disease. Getty Images 10. Cauliflower Cauliflower brings the crunch, paired with plenty of vitamins C, B6, B9 and K, along with fiber. It also contains compounds your body can use to neutralize certain toxins, a big help when your kidneys aren't doing their best filtration work. Cauliflower does contain some potassium and phosphorus, though, so while it makes the list of foods good for kidneys, people with CKD may want to moderate their intake. 11. Egg whites Egg whites are specifically recommended for people with kidney problems. They give you a way to increase your protein levels -- which can be important with later-stage CKD, especially if you're on dialysis. 12. Arugula Arugula is packed with nutrients your body needs like magnesium, iron, calcium and vitamins A, B9, C and K. Plus, it's antioxidant-rich and has glucosinolates, which can help your body protect itself against a range of cancer types. You can eat arugula raw (it's a great salad base), but you can also sprinkle it over whatever you're whipping up. It's great on pizzas, in omelets and with pasta, for example. 13. Apples Apples deliver the cancer-fighting quercetin and fiber that can help to keep your cholesterol and blood sugar at healthy levels. They've got plenty of antioxidants. Better yet, they're easy to work into your diet. Leave a bowl of apples on your counter and you'll have a kidney-healthy, grab-and-go snack whenever you need one.
Time Magazine
27 minutes ago
- Time Magazine
Cutting mRNA Research Could Be Our Deadliest Mistake Yet
The U.S. Department of Health and Human Services (HHS) recently announced it will wind down funding for mRNA vaccine development—which could prove to be one of the costliest, deadliest decisions HHS Secretary Robert F. Kennedy Jr. will make during his tenure. HHS has already scaled back access to and recommendations for COVID-19 vaccines—a decision experts are deeply concerned about—and Kennedy's frequently misinformed views on vaccines continue to fan the flames of anti-vaccination attitudes. Now, Kennedy's failure to fully explore the potential of mRNA vaccines could stagnate research that has the potential to save millions of lives around the world. The dark cloud of COVID-19, one of the deadliest infectious disease outbreaks in history, can hardly be thought of as having a silver lining. But the nearest thing to a glimmer of a positive would be that the fast development of COVID-19 vaccines helped prevent many more deaths and led to rapid progress in our understanding and use of mRNA technology. This greater understanding is now being explored as potential preventions or therapies for a wide range of diseases, from H5N1 bird flu and HIV to cancer. Terminating 22 mRNA projects will not only directly set back research on mRNA vaccines for infectious diseases including flu; it will also arguably have negative knock-on effects for researchers the world over exploring personalized treatments for noncommunicable diseases like cancer. Early research on some novel uses of mRNA is promising. For example, a preliminary trial of an mRNA HIV vaccine found that 80% of participants generated neutralizing antibodies, which in theory could help block HIV—pending further research and development. A melanoma mRNA vaccine, when combined with existing treatment, reduced the risk of death or disease recurrence by nearly 50%. (The vaccine is currently being tested further in a full scale Phase 3 clinical trial). Even more amazingly, personalized vaccines—where vaccines are created specifically for an individual using information from their cancer to optimize their immune response—using mRNA technology have even been proposed as a universal vaccine adaptable for all cancers. Read More: The CDC Shooting is a Dark Sign for Science and America Much of the research on personalized mRNA cancer vaccines is in some way indebted to gains in knowledge made from COVID-19 research, and it stands to reason that pulling such a large amount of funding from mRNA projects will slow down further progress in these areas. Approximately $500 million worth of research funding would almost certainly have advanced the scientific community's fundamental understanding of how, and to what extent, mRNA technology works and how it could be applied to prevent and fight disease. Also problematic is the manner in which HHS under Kennedy conveys their decisions. In announcing the funding withdrawal, HHS states it 'will focus on platforms with stronger safety records and transparent clinical and manufacturing data practices.' This implies that mRNA vaccines have not been properly or transparently tested—which is not true. The safety of COVID-19 mRNA vaccines has been demonstrated in numerous studies and systematic evidence reviews. Like pretty much all vaccines and treatments, mRNA vaccines are not without side effects, but evidence shows that any adverse events are nearly always mild and short-lived. COVID-19 vaccines have already saved millions of lives globally, with mRNA vaccines accounting for a significant majority of all doses administered in many countries. Kennedy's claim that 'mRNA technology poses more risk than benefits' is almost farcical in light of scientific evidence. Moreover, the whole purpose of clinical research is to test whether new scientific innovations—like novel applications of mRNA into different diseases—are safe and effective in the first place. Kennedy has long spoken of how we need more evidence and testing on mRNA vaccines, and so it is painfully ironic that he is pulling funding for research which would enable the scientific community to do just that. Read More: An mRNA Melanoma Vaccine Shows Promise Perhaps most concerning is the caliber of evidence upon which decisions with such massive implications are being made. In an HHS announcement of the termination of mRNA projects, Kennedy claims 'the data show these vaccines fail to protect effectively against upper respiratory infections like COVID and flu.' The truth is, initial vaccines and booster doses have been shown to be very effective against reducing infection, hospitalization, and death from COVID-19. Kennedy does not even provide links or citations to systematic reviews or meta-analyses in reputable journals, the gold standard methods for scientific evidence. Rather, he simply links to an online evidence review which cherry picks studies searching only for the harms—and not the overall safety, effectiveness, or cost-benefit analysis—of the mRNA vaccines. The report does not describe the methods used to select and review studies, nor does it appear itself to have been peer-reviewed by other scientists. It almost certainly wouldn't be publishable in a scientific journal, yet it is being used as evidence to justify the fate of half a billion dollars of research funds. This is another example of how fringe viewpoints on mRNA technology, instead of the best available scientific evidence, are under Kennedy and HHS becoming the new mainstream. The U.S. has been at the forefront of developing mRNA technology for the past few decades, from the Nobel Prize-winning research of professors Katalin Kariko and Drew Weissman at the University of Pennsylvania on mRNA, to the key role of U.S.-based pharmaceutical companies in vaccine production and rollout. Perhaps other countries, companies, and funding sources will offset this funding loss and lead the development of mRNA vaccine innovations. Large investments are already being made in the U.K. and China, for example. That would be to the detriment of U.S. scientific innovation and progress. Kennedy is right to scrutinize the potential overreach of the pharmaceutical industry, and to ensure their research and development is ethical and transparent. However, his seemingly personal war against "Big Pharma" and ideological opposition to mRNA risks stunting research that could one day help prevent the next pandemic or even provide cures for hitherto incurable cancers.
an hour ago
AstraZeneca launches at-home FluMist nasal spray delivery
AstraZeneca is making flu protection more convenient with the launch of an at-home delivery option for FluMist, its nasal spray flu vaccine, the company announced Friday. On the market since 2003, FluMist was previously only available at pharmacies or doctors' offices. Beginning Friday, eligible customers can order it online and have it shipped directly to their door, allowing parents to vaccinate their children at home without shots or a trip to the pharmacy. The spray can be self-administered by adults up to age 49, while caregivers can give it to children ages 2–17, the company said. The FDA approved FluMist for self- and caregiver-administration in September 2024, after research showed adults over 18 could safely and effectively administer it to eligible individuals. AstraZeneca hopes the needle-free option and at-home convenience will boost vaccination rates this year. Last year's flu season saw the highest number of flu-related deaths for children for a non-pandemic year -- 267 -- since the 2009 H1N1 pandemic, according to the Centers for Disease Control and Prevention. Health experts stress that vaccination remains the best protection against the virus, though getting kids vaccinated can be a challenge. The CDC continues to recommend that everyone 6 months and older get a flu vaccine this fall. Most health insurance plans are expected to cover the cost, with a shipping fee for four FluMist doses estimated at under $10. The company added for those who qualify, the nasal spray offers safety and effectiveness comparable to traditional flu shots.
